Dawn Earl

2.7k total citations
15 papers, 539 citations indexed

About

Dawn Earl is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dawn Earl has authored 15 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dawn Earl's work include Connective tissue disorders research (3 papers), Congenital heart defects research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Dawn Earl is often cited by papers focused on Connective tissue disorders research (3 papers), Congenital heart defects research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Dawn Earl collaborates with scholars based in United States, United Kingdom and Canada. Dawn Earl's co-authors include John M. Graham, Xiuqing Guo, Jeannie Kreutzman, Raymond Wang, Jinrui Cui, D. Sloan Stribling, H.-J. Smith, Elaine M. Faustman, Jay Shendure and James M. Swanson and has published in prestigious journals such as PEDIATRICS, The American Journal of Human Genetics and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dawn Earl

14 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Earl United States 10 347 245 100 84 55 15 539
Beate Mitulla Germany 10 262 0.8× 187 0.8× 160 1.6× 102 1.2× 37 0.7× 13 477
Rosemarie Smith United States 11 336 1.0× 409 1.7× 151 1.5× 55 0.7× 105 1.9× 21 744
A. David France 13 230 0.7× 326 1.3× 115 1.1× 41 0.5× 29 0.5× 42 579
Odile Boute France 13 222 0.6× 162 0.7× 129 1.3× 47 0.6× 36 0.7× 31 471
Valère Cacheux France 10 417 1.2× 415 1.7× 128 1.3× 37 0.4× 166 3.0× 12 847
Anna L. Mitchell United States 14 324 0.9× 176 0.7× 42 0.4× 32 0.4× 127 2.3× 24 535
Marion Gérard‐Blanluet France 13 158 0.5× 200 0.8× 61 0.6× 31 0.4× 23 0.4× 24 399
Thomas A. Maher United States 13 147 0.4× 270 1.1× 112 1.1× 30 0.4× 137 2.5× 23 586
Alice S. Brooks Netherlands 14 325 0.9× 304 1.2× 97 1.0× 29 0.3× 69 1.3× 29 595
Sharan Goobie Canada 15 281 0.8× 162 0.7× 37 0.4× 88 1.0× 18 0.3× 29 504

Countries citing papers authored by Dawn Earl

Since Specialization
Citations

This map shows the geographic impact of Dawn Earl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Earl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Earl more than expected).

Fields of papers citing papers by Dawn Earl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Earl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Earl. The network helps show where Dawn Earl may publish in the future.

Co-authorship network of co-authors of Dawn Earl

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Earl. A scholar is included among the top collaborators of Dawn Earl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Earl. Dawn Earl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Earl, Dawn, et al.. (2025). Targeted Therapies in Neurofibromatosis Type 1. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 199(3). 154–160.
2.
Hostetler, Ellen M., Ana Beleza‐Meireles, Ingrid Scurr, et al.. (2022). Expanding ACTA2 genotypes with corresponding phenotypes overlapping with smooth muscle dysfunction syndrome. American Journal of Medical Genetics Part A. 188(8). 2389–2396. 8 indexed citations
3.
Quintero‐Rivera, Fabiola, Kelly L. Jones, Małgorzata J.M. Nowaczyk, et al.. (2021). 5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation. Human Genetics. 140(4). 681–690. 8 indexed citations
4.
Wenger, Tara, et al.. (2016). Role of Pediatric Geneticists in Craniofacial Teams: The Identification of Craniofacial Conditions with Cancer Predisposition. The Journal of Pediatrics. 175. 216–223.e1. 3 indexed citations
5.
Tokita, Mari, Ghayda Mirzaa, Nicola Dikow, et al.. (2014). Five children with deletions of 1p34.3 encompassing AGO1 and AGO3. European Journal of Human Genetics. 23(6). 761–765. 28 indexed citations
6.
Andersen, Erica, John C. Carey, Dawn Earl, et al.. (2013). Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf–Hirschhorn Syndrome. European Journal of Human Genetics. 22(4). 464–470. 30 indexed citations
7.
Below, Jennifer E., Dawn Earl, Kathryn M. Shively, et al.. (2012). Whole-Genome Analysis Reveals that Mutations in Inositol Polyphosphate Phosphatase-like 1 Cause Opsismodysplasia. The American Journal of Human Genetics. 92(1). 137–143. 44 indexed citations
8.
Below, Jennifer E., Anita E. Beck, Heidi Gildersleeve, et al.. (2012). Mutations in ECEL1 Cause Distal Arthrogryposis Type 5D. The American Journal of Human Genetics. 92(1). 150–156. 52 indexed citations
9.
Rosenfeld, Jill A., Kyae Hyung Kim, Brad Angle, et al.. (2012). Further Evidence of Contrasting Phenotypes Caused by Reciprocal Deletions and Duplications: Duplication of NSD1 Causes Growth Retardation and Microcephaly. Molecular Syndromology. 3(6). 247–254. 37 indexed citations
10.
Graham, John M., et al.. (2005). Deformational brachycephaly in supine-sleeping infants. The Journal of Pediatrics. 146(2). 253–257. 73 indexed citations
11.
Graham, John M., et al.. (2005). Management of deformational plagiocephaly: Repositioning versus orthotic therapy. The Journal of Pediatrics. 146(2). 258–262. 137 indexed citations
12.
Yano, Shoji, et al.. (2003). Johnson–McMillin syndrome, a neuroectodermal syndrome with conductive hearing loss and microtia: Report of a new case. American Journal of Medical Genetics Part A. 120A(3). 400–405. 9 indexed citations
13.
Wang, Raymond, et al.. (2001). Syndromic Ear Anomalies and Renal Ultrasounds. PEDIATRICS. 108(2). e32–e32. 84 indexed citations
14.
Earl, Dawn, et al.. (2000). Marden-Walker syndrome: case report and review. Genetics in Medicine. 2(1). 87–87. 1 indexed citations
15.
Smith, H.-J., et al.. (1983). Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.. Journal of Pharmacology and Experimental Therapeutics. 226(1). 211–216. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026